文献速递妇科产科

以证据为导向的质量改进:卵巢癌复杂肿瘤细胞减灭术后影响最大的并发症

Using evidence to direct quality improvement efforts: Defining the highest impact complications after complex cytoreductive surgery for ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2019-11-27

该研究基于NSQIP数据库1434例接受复杂肿瘤细胞减灭术(含结肠切除)的卵巢癌患者,采用人群归因分数(PAF)量化各并发症对不良结局的贡献。吻合口漏(以器官腔隙手术部位感染为替代指标)是不良临床结局和资源利用增加的最大贡献因素,PAF分别为33.4%和75.7%(延长住院)、17.1%(再入院)。

要点

  • 吻合口漏是不良临床结局的最大贡献因素,PAF为33.4%(95%CI: 22.3%-45.6%)。
  • 吻合口漏对延长住院的PAF为75.7%(95%CI: 51.4%-90.0%),对再入院的PAF为17.1%(95%CI: 11.5%-22.6%)。
  • 输血是非居家出院的最大贡献因素,PAF为22.8%(95%CI: 0.7%-42.4%)。

核心结论

  • 吻合口漏是复杂肿瘤细胞减灭术后不良临床结局和资源利用增加的最大贡献因素。
  • 减少吻合口漏及其影响的质量改进应成为卵巢癌手术的最高优先事项。

研究设计与样本

  • 基于NSQIP数据库的回顾性队列研究,纳入2012年1月1日至2016年12月31日期间因卵巢癌接受复杂肿瘤细胞减灭术(定义为含结肠切除的肿瘤细胞减灭术)的1434例女性。
  • 采用人群归因分数(PAF)量化每种主要并发症对不良结局的贡献,以器官腔隙手术部位感染作为吻合口漏的替代指标。

主要发现

  • 任何不良临床结局(死亡、再手术或终末器官功能障碍的复合终点)发生于9.1%的女性。
  • 吻合口漏是不良临床结局的最大贡献因素,PAF=33.4%(95%CI: 22.3%-45.6%)。
  • 延长住院发生率为23.7%,非居家出院为10.7%,非计划再入院为14.8%。
  • 吻合口漏是延长住院的最大贡献因素,PAF=75.7%(95%CI: 51.4%-90.0%),也是再入院的最大贡献因素,PAF=17.1%(95%CI: 11.5%-22.6%)。
  • 输血是非居家出院的最大贡献因素,PAF=22.8%(95%CI: 0.7%-42.4%)。

临床怎么用

  • 卵巢癌复杂肿瘤细胞减灭术的质量改进应优先关注减少吻合口漏及其影响。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to identify postoperative complications with the greatest impact on patient-centric outcomes to serve as high yield QI targets in ovarian cancer (OC) surgery. METHODS: Women undergoing complex CRS (defined as cytoreductive surgery with colon resection) for OC between January 1, 2012 and 12/31/2016 were identified from the National Surgical Quality Improvement Program (NSQIP) database. We determined the population attributable fraction (PAF) to quantify the contribution of each major complication towards adverse outcomes. PAF represents the burden of adverse outcomes that could be eliminated if the corresponding complication was prevented. Organ space surgical site infection (SSI) was used as a surrogate for anastomotic leak (AL). RESULTS: A total of 1434 women met inclusion criteria. Any adverse clinical outcome (composite of death, reoperation, or end organ dysfunction) occurred in 9.1% of women, and AL was the largest contributor to adverse clinical outcomes [PAF = 33.4% (95%CI: 22.3%-45.6%)]. The rates of increased resource utilization were as follows; prolonged hospitalization in 23.7%, non-home discharge in 10.7% and unplanned readmission in 14.8% of women. AL was the largest contributor to prolonged hospitalizations [PAF = 75.7% (95%CI: 51.4%-90.0%)] and readmissions [PAF = 17.1% (95%CI: 11.5%-22.6%)]; while transfusion was the largest contributor to non-home discharge [PAF = 22.8% (95%CI: 0.7%-42.4%)]. By comparison, the impact of other complications, including those targeted by the Surgical Care Improvement Project (SCIP), such as incisional SSI, venous thromboembolism, myocardial infarction, and urinary infection, was small. CONCLUSIONS: Anastomotic leak is the largest contributor to adverse clinical outcomes and increased resource utilization after complex cytoreductive surgery. Quality improvement efforts to reduce AL and its impact should be of highest priority in OC surgery.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Narasimhulu DM, Bews KA, Hanson KT, et al. Using evidence to direct quality improvement efforts: Defining the highest impact complications after complex cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2019. PMID: 31785863. doi:10.1016/j.ygyno.2019.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。